Literature DB >> 28488625

Genetics of pituitary adenomas.

Mario Shaid1, Márta Korbonits1.   

Abstract

Clinically relevant pituitary tumors presenting with altered hormonal secretion or mass effect represent a significant proportion of patients in endocrinology clinics. However, in recent years, these patients are also referred to clinical genetic services due to possible germline mutations causing syndromic or isolated pituitary adenomas. While somatic mutations have been identified in GNAS, USB8, PIK3CA, GPR101 and rarely in RAS, germline mutations have been identified in MEN1, cyclin dependent kinase inhibitor genes, AIP, DICER1, PRKAR1A, PRKACA, SDH genes and GPR101. In this review, we present a short overview of pituitary adenoma classifications, pituitary development and somatic and germline genetic changes identified in these adenomas.

Entities:  

Mesh:

Year:  2017        PMID: 28488625     DOI: 10.4103/neuroindia.NI_330_17

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  2 in total

1.  Whole exome sequencing reveals novel risk genes of pituitary neuroendocrine tumors.

Authors:  Raitis Peculis; Vita Rovite; Kaspars Megnis; Inga Balcere; Austra Breiksa; Jurijs Nazarovs; Janis Stukens; Ilze Konrade; Jelizaveta Sokolovska; Valdis Pirags; Janis Klovins
Journal:  PLoS One       Date:  2022-08-26       Impact factor: 3.752

2.  Molecular Markers of Telomerase Complex for Patients with Pituitary Adenoma.

Authors:  Greta Gedvilaite; Alvita Vilkeviciute; Brigita Glebauskiene; Loresa Kriauciuniene; Rasa Liutkeviciene
Journal:  Brain Sci       Date:  2022-07-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.